Gupta, Ravindra K.
University of Cambridge · Africa Health Research Institute
20 papers on CoChatORCID 0000-0001-9751-1808
Most cited papers
- Verified
SARS-CoV-2 variants, spike mutations and immune escape
Harvey, W. T., Carabelli, A. M., Jackson, B., Gupta, R. K., Thomson, E. C., Harrison, E. M., Ludden, C., Reeve, R., Rambaut, A., COVID-19 Genomics UK (COG-UK) Consortium, et al. (2021) · Nature Reviews Microbiology
SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches
Cited by 3,528
- Verified
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
Mlcochova, P., Kemp, S. A., Dhar, M. S., Papa, G., Meng, B., Ferreira, I. A. T. M., Datir, R., Collier, D. A., Albecka, A., Singh, S., et al. (2021) · Nature
SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies
Cited by 1,337
- Verified
SARS-CoV-2 Omicron spike mediated immune escape and tropism shift
Gupta, R. (2022) · Nature
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 1,147
- Verified
SARS-CoV-2 Omicron spike mediated immune escape and tropism shift
Meng, B., Ferreira, I. A. T. M., Abdullahi, A., Goonawardane, N., Saito, A., Kimura, I., Yamasoba, D., Gerba, P. P., Fatihi, S., Rathore, S., et al. (2021) · Nature
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 1,147
- Verified
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
Meng, B., Abdullahi, A., Ferreira, I. A. T. M., Goonawardane, N., Saito, A., Kimura, I., Yamasoba, D., Gerber, P. P., Fatihi, S., Rathore, S., et al. (2022) · Nature
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 1,146
- Verified
SARS-CoV-2 evolution during treatment of chronic infection
Kemp, S. A., Collier, D. A., Datir, R. P., Ferreira, I. A. T. M., Gayed, S., Jahun, A., Hosmillo, M., Rees-Spear, C., Mlcochova, P., Lumb, I. U., et al. (2021) · Nature
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 1,097
- Verified
The biological and clinical significance of emerging SARS-CoV-2 variants
Tao, K., Tzou, P. L., Nouhin, J., Gupta, R. K., de Oliveira, T., Kosakovsky Pond, S. L., Fera, D., & Shafer, R. W. (2021) · Nature Reviews Genetics
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 1,009
- Verified
Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2
Collier, D. A., Ferreira, I. A. T. M., Kotagiri, P., Datir, R. P., Lim, E. Y., Touizer, E., Meng, B., Abdullahi, A., The CITIID-NIHR BioResource COVID-19 Collaboration, Principal Investigators, et al. (2021) · Nature
SARS-CoV-2 and COVID-19 ResearchImmune responses and vaccinations
Cited by 751
- Verified
SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies
Collier, D. A., De Marco, A., Ferreira, I. A. T. M., Meng, B., Datir, R., Walls, A. C., Kemp S, S. A., Bassi, J., Pinto, D., Fregni, C. S., et al. (2021) · Nature
SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies
Cited by 729
- Verified
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Collier, D. A., De Marco, A., Ferreira, I. A. T. M., Meng, B., Datir, R. P., Walls, A. C., Kemp, S. A., Bassi, J., Pinto, D., Silacci-Fregni, C., et al. (2021) · Nature
SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies
Cited by 728
- Verified
Genomic characterization and Epidemiology of an emerging SARS-CoV-2 variant in Delhi, India
Dhar, M. S., Marwal, R., Radhakrishnan, V., Ponnusamy, K., Jolly, B., Bhoyar, R. C., Sardana, V., Naushin, S., Rophina, M., Mellan, T. A., et al. (2021) · Science
SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies
Cited by 296
- Verified
The emergence and ongoing convergent evolution of the N501Y lineages coincides with a major global shift in the SARS-CoV-2 selective landscape
Martin, D. P., Weaver, S., Tegally, H., San, E. J., Shank, S. D., Wilkinson, E., Lucaci, A. G., Giandhari, J., Naidoo, S., Pillay, Y., et al. (2021) · Cell
SARS-CoV-2 and COVID-19 ResearchEvolution and Genetic Dynamics
Cited by 291
- Verified
Recurrent emergence and transmission of a SARS-CoV-2 spike deletion H69/V70
Kemp, S. A., Meng, B., Ferriera, I. A., Datir, R., Harvey, W. T., Papa, G., Lytras, S., Collier, D. A., Mohamed, A., Gallo, G., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory)
SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies
Cited by 252
- Verified
The HUSH complex is a gatekeeper of type I interferon through epigenetic regulation of LINE-1s
Tunbak, H., Enriquez-Gasca, R., Tie, C. H. C., Gould, P. A., Mlcochova, P., Gupta, R. K., Fernandes, L., Holt, J., van der Veen, A. G., Giampazolias, E., et al. (2020) · Nature Communications
interferon and immune responsesChromosomal and Genetic Variations
Cited by 162
- Verified
SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion
Ferreira, I. A. T. M., Kemp, S. A., Datir, R., Saito, A., Meng, B., Rakshit, P., Takaori-Kondo, A., Kosugi, Y., Uriu, K., Kimura, I., et al. (2021) · The Journal of Infectious Diseases
SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches
Cited by 151
- Verified
Bacterial pneumonia and pandemic influenza planning.
Gupta, R. K., George, R., & Nguyen-Van-Tam, J. S. (2008) · Emerging infectious diseases
Influenza Virus Research StudiesPneumonia and Respiratory Infections
Cited by 132
- Verified
SARS-CoV-2 B.1.617.2 Delta variant replication, sensitivity to neutralising antibodies and vaccine breakthrough
Mlcochova, P., Kemp, S., Dhar, M. S., Papa, G., Meng, B., Mishra, S., Whittaker, C., Mellan, T., Ferreira, I., Datir, R., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory)
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 90
- Verified
Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses
Needham, E. J., Ren, A. L., Digby, R. J., Norton, E. J., Ebrahimi, S., Outtrim, J. G., Chatfield, D. A., Manktelow, A. E., Leibowitz, M. M., Newcombe, V. F. J., et al. (2022) · Brain
Long-Term Effects of COVID-19COVID-19 Clinical Research Studies
Cited by 90
- Verified
Full-length HIV-1 Gag determines protease inhibitor susceptibility within in-vitro assays
Gupta, R. K., Kohli, A., McCormick, A. L., Towers, G. J., Pillay, D., & Parry, C. M. (2010) · AIDS
HIV/AIDS drug development and treatmentHIV Research and Treatment
Cited by 71
- Verified
Human Immunodeficiency Virus-1 Viral Load Is Elevated in Individuals With Reverse-Transcriptase Mutation M184V/I During Virological Failure of First-Line Antiretroviral Therapy and Is Associated With Compensatory Mutation L74I
Gregson, J., Rhee, S. Y., Datir, R., Pillay, D., Perno, C. F., Derache, A., Shafer, R. S., & Gupta, R. K. (2020) · The Journal of Infectious Diseases
HIV/AIDS drug development and treatmentHIV Research and Treatment
Cited by 24
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free